Paratek Pharmaceuticals Stock Price - PRTK

5.05
0.14 (2.85%)
Upgrade to Real-Time
Afterhours (Closed)
4.91
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Paratek Pharmaceuticals Inc PRTK NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.24 5.14% 4.91 4.73 5.04 4.85 4.67 00:00:02
Bid Price Ask Price Spread Spread % News
4.92 10.00 5.08 50.8% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,973 1,291,530 $ 4.87 $ 6,293,433 540,952 2.50 - 5.89
Last Trade Time Type Quantity Stock Price Currency
18:04:55 44 $ 5.05 USD

Paratek Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 211.78M 43.13M 41.09M $ 16.54M $ - -3.93 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Paratek Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PRTK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.305.044.244.58341,3630.6114.19%
1 Month4.595.044.034.45503,0300.326.97%
3 Months3.255.042.503.90620,2191.6651.08%
6 Months3.045.282.503.94979,2641.8761.51%
1 Year3.825.892.503.90720,4901.0928.53%
3 Years20.7529.002.509.67595,903-15.84-76.34%
5 Years29.7330.9052.5011.26440,249-24.82-83.48%

Paratek Pharmaceuticals Description

Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's medical research is based on tetracycline chemistry and biology to create two antibacterials: omadacycline and sarecycline. Omadacycline is an antibacterial for skin infections and treatment of community-acquired bacterial pneumonia. Sarecycline is designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals is also involved in research to treat multiple sclerosis, spinal muscular atrophy, and systemic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases.


Your Recent History
NASDAQ
PRTK
Paratek Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.